BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19267881)

  • 1. Serum withdrawal up-regulates human SIRT1 gene expression in a p53-dependent manner.
    Shang L; Zhou H; Xia Y; Wang H; Gao G; Chen B; Liu Q; Shao C; Gong Y
    J Cell Mol Med; 2009 Oct; 13(10):4176-84. PubMed ID: 19267881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-nucleotide variation in a p53-binding site affects nutrient-sensitive human SIRT1 expression.
    Naqvi A; Hoffman TA; DeRicco J; Kumar A; Kim CS; Jung SB; Yamamori T; Kim YR; Mehdi F; Kumar S; Rankinen T; Ravussin E; Irani K
    Hum Mol Genet; 2010 Nov; 19(21):4123-33. PubMed ID: 20693263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT1 knockdown up-regulates p53 and p21/Cip1 expression in renal adenocarcinoma cells but not in normal renal-derived cells in a deacetylase-independent manner.
    Fujino T; Yokokawa R; Oshima T; Hayakawa M
    J Toxicol Sci; 2018; 43(12):711-715. PubMed ID: 30518708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirtuin1-p53: A potential axis for cancer therapy.
    Yin JY; Lu XT; Hou ML; Cao T; Tian Z
    Biochem Pharmacol; 2023 Jun; 212():115543. PubMed ID: 37037265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming.
    Ong ALC; Ramasamy TS
    Ageing Res Rev; 2018 May; 43():64-80. PubMed ID: 29476819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A deacetylase-deficient SIRT1 variant opposes full-length SIRT1 in regulating tumor suppressor p53 and governs expression of cancer-related genes.
    Shah ZH; Ahmed SU; Ford JR; Allison SJ; Knight JR; Milner J
    Mol Cell Biol; 2012 Feb; 32(3):704-16. PubMed ID: 22124156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methyltransferase Set7/9 regulates p53 activity by interacting with Sirtuin 1 (SIRT1).
    Liu X; Wang D; Zhao Y; Tu B; Zheng Z; Wang L; Wang H; Gu W; Roeder RG; Zhu WG
    Proc Natl Acad Sci U S A; 2011 Feb; 108(5):1925-30. PubMed ID: 21245319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P53 and Sirt1: routes of metabolism and genome stability.
    Gonfloni S; Iannizzotto V; Maiani E; Bellusci G; Ciccone S; Diederich M
    Biochem Pharmacol; 2014 Nov; 92(1):149-56. PubMed ID: 25218422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT1 confers protection against UVB- and H2O2-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes.
    Cao C; Lu S; Kivlin R; Wallin B; Card E; Bagdasarian A; Tamakloe T; Wang WJ; Song X; Chu WM; Kouttab N; Xu A; Wan Y
    J Cell Mol Med; 2009 Sep; 13(9B):3632-43. PubMed ID: 18681908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EVI1 up-regulates the stress responsive gene SIRT1 which triggers deacetylation and degradation of EVI1.
    Pradhan AK; Kuila N; Singh S; Chakraborty S
    Biochim Biophys Acta; 2011; 1809(4-6):269-75. PubMed ID: 21555002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipase D2 is a positive regulator of sirtuin 1 and modulates p53-mediated apoptosis via sirtuin 1.
    Lee H; Jung TY; Lim SH; Choi EJ; Lee J; Min DS
    Exp Mol Med; 2021 Sep; 53(9):1287-1297. PubMed ID: 34471223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutrient availability regulates SIRT1 through a forkhead-dependent pathway.
    Nemoto S; Fergusson MM; Finkel T
    Science; 2004 Dec; 306(5704):2105-8. PubMed ID: 15604409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S; Sun L; Huang F
    Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells.
    Yarahmadi S; Abdolvahabi Z; Hesari Z; Tavakoli-Yaraki M; Yousefi Z; Seiri P; Hosseinkhani S; Nourbakhsh M
    Gene; 2019 Aug; 711():143939. PubMed ID: 31220581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive silencing of target-sharing microRNAs is a mechanism for SIRT1 overexpression in cancer.
    Kiga K; Fukuda-Yuzawa Y; Tanabe M; Tsuji S; Sasakawa C; Fukao T
    RNA Biol; 2014; 11(11):1347-54. PubMed ID: 25483038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT1 and p53, effect on cancer, senescence and beyond.
    Yi J; Luo J
    Biochim Biophys Acta; 2010 Aug; 1804(8):1684-9. PubMed ID: 20471503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleolar protein NOC4L inhibits tumorigenesis and progression by attenuating SIRT1-mediated p53 deacetylation.
    Jia X; Liu H; Ren X; Li P; Song R; Li X; Guo Y; Li X
    Oncogene; 2022 Sep; 41(39):4474-4484. PubMed ID: 36030331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the significance of silent information regulator type-1 in Angioimmunoblastic T-cell lymphoma is greater association with tumorigenesis and has strong implications for adverse prognosis.
    Ren Y; Gu Y; Wang W; Wang J; Li X; Wang Y; Gao H; Dong X; Tian Y
    Cell Cycle; 2016 Jun; 15(12):1545-51. PubMed ID: 27124741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.
    Chen WY; Wang DH; Yen RC; Luo J; Gu W; Baylin SB
    Cell; 2005 Nov; 123(3):437-48. PubMed ID: 16269335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity protein in human cervical cancer cells.
    Allison SJ; Jiang M; Milner J
    Aging (Albany NY); 2009 Mar; 1(3):316-27. PubMed ID: 20157519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.